Screening

American Red Cross Launches Genetic Technology to Detect Viruses

Published in Hepatitis Weekly, April 19th, 1999

The American Red Cross is pioneering the use of an innovative technology that could add an additional layer of safety to the 14 million units of blood components distributed by the Red Cross to hospitals nationwide each year.

The Red Cross is investigating a genetic test - nucleic acid testing or NAT - for the early detection of transfusion-transmitted viruses, such as HIV and hepatitis C virus (HCV), at its National Genome Testing Laboratory in San Diego, California.

Already the Red Cross' use of NAT has detected the first unit of HCV infected donor blood that was negative by standard screening tests, thus preventing a probable transmission of the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (1999-04-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry